Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Reexamination Certificate
2011-03-29
2011-03-29
Hayes, Robert C (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
C514S643000
Reexamination Certificate
active
07915317
ABSTRACT:
The present invention relates to aqueous pharmaceutical compositions comprising 2,6-diisopropylphenol (propofol). A composition of the present invention can comprise propofol and two or more excipients as an aqueous mixture. The propofol containing compositions are preferably sterile and are parenterally administered to any animal, including humans. The compositions are also chemically and physically stable over a wide range of environmental conditions.
REFERENCES:
patent: 4056635 (1977-11-01), Glen et al.
patent: 4452817 (1984-06-01), Glen et al.
patent: 4798846 (1989-01-01), Glen et al.
patent: 5296161 (1994-03-01), Wiersema et al.
patent: 5635540 (1997-06-01), Edlich et al.
patent: 5637625 (1997-06-01), Haynes
patent: 5731355 (1998-03-01), Jones et al.
patent: 5962536 (1999-10-01), Komer
patent: 5990241 (1999-11-01), Emanuele et al.
patent: 6077545 (2000-06-01), Roskos et al.
patent: 6100302 (2000-08-01), Pejaver et al.
patent: 6140373 (2000-10-01), May et al.
patent: 6140374 (2000-10-01), May et al.
patent: 6150423 (2000-11-01), Carpenter
patent: 6277410 (2001-08-01), Kabanov et al.
patent: 6383471 (2002-05-01), Chen et al.
patent: 6534547 (2003-03-01), Carpenter
patent: 6623765 (2003-09-01), Dennis et al.
patent: 6638537 (2003-10-01), Dennis et al.
patent: 6743436 (2004-06-01), Lee et al.
patent: 7034013 (2006-04-01), Thompson et al.
patent: 7166303 (2007-01-01), Meadows et al.
patent: 2002/0006442 (2002-01-01), Mishra et al.
patent: 2002/0022667 (2002-02-01), Pace et al.
patent: 2002/0107291 (2002-08-01), De Tommaso
patent: 2003/0138489 (2003-07-01), Meadows et al.
patent: 2003/0165544 (2003-09-01), Mishra et al.
patent: 2004/0220283 (2004-11-01), Zhang et al.
patent: 2004/0265388 (2004-12-01), Zhang et al.
patent: 2005/0009731 (2005-01-01), Desai et al.
patent: 2005/0027019 (2005-02-01), Zhang et al.
patent: 2 298 789 (1996-09-01), None
patent: 2002-521434 (2002-07-01), None
patent: 97/10814 (1997-03-01), None
patent: WO 00/06142 (2000-02-01), None
patent: 00/21517 (2000-04-01), None
patent: WO 00/24376 (2000-05-01), None
patent: 00/78301 (2000-12-01), None
patent: 01/64187 (2001-09-01), None
patent: 01/89514 (2001-11-01), None
patent: WO 01/97779 (2001-12-01), None
patent: WO 01/97796 (2001-12-01), None
patent: WO 02/09671 (2002-02-01), None
patent: WO 02/45709 (2002-06-01), None
patent: WO 02/074200 (2002-09-01), None
patent: 03/017977 (2003-03-01), None
patent: 03/030862 (2003-04-01), None
patent: WO 2004/032910 (2004-04-01), None
Adams, Monica L. et al., “Amphiphilic Block Copolymers for Drug Delivery” Journal of Pharm. Sciences, vol. 92, No. 7, Jul. 2003.
Dutta, Sandeep et al., “Formulation-dependent Pharmacokinetics and Pharmacodynamics of Propofol in Rats”, J. Pharm. Pharmacol., 1998, 50: 37-42, Aug. 1, 1997.
Ivanova, Rouja et al., “Interaction of Poloxamer Block Copolymers with Cosolvents and Surfactants”, Colloids and Surfaces, Physiochemical and Engineering Aspects 183-185 (2001) p. 41-53.
Momot, Konstantin et al., “NMR Study of the Association of Propofol with Nonionic Surfactants”, School of Molecular and Microbial Biosciences, University of Sydney, Sydney, NS 2006, Australia, and DBL Australia Pty. Ltd., Level 21, 390 St. Kilda Road, Melbourne, Vic 3004, Austalia.
F.F. Busta et al., Chemical Food Preservatives, Antimicrobial Preservatives and Protectants, Chapter 35, pp. 656-694.
P. Bulet et al., Antimicrobial Peptides in Insects; Structure and Function, Developmental and Comparative Immunology, 23 (1999) 329-344.
Official Action of Aug. 11, 2005 in U.S. Appl. No. 10/766,631 (with attachments).
Amendment and Reply Under 37 CRF §1.111, filed Nov. 8, 2005 in response to Official Action of Aug. 11, 2005 in U.S. Appl. No. 10/766,631. .
Official Action of Feb. 8, 2006 in U.S. Appl. No. 10/766,631.
Amendment filed Jul. 10, 2006 in response to Official Action of Feb. 2, 2006 in U.S. Appl. No. 10/766,631.
Official Action of Oct. 19, 2006 in U.S. Appl. No. 10/766,631.
Amendment filed Jan. 5, 2007 in response to Official Action of Oct. 19, 2006 in U.S. Appl. No. 10/766,631.
Official Action of Sep. 12, 2007 in U.S. Appl. No. 10/766,631 (with attachments).
Amendment filed Nov. 26, 2007 in response to Official Action of Sep. 12, 2007 in U.S. Appl. No. 10/766,631.
Supplemental Response filed Mar. 26, 2008 in response to Applicant's Response of Nov. 26, 2007 in U.S. Appl. No. 10/766,631.
Official Action of Jun. 12, 2008 in U.S. Appl. No. 10/766,631 (with attachments).
Official Action of Jul. 28, 2005 in U.S. Appl. No. 10/677,747 (with attachments).
Amendment and Reply Under 37 CFR §1.111, filed Nov. 28, 2005 in response to Official Action dated Jul. 28, 2005 in U.S. Appl. No. 10/677,747.
Official Action of Jun. 30, 2006 in U.S. Appl. No. 10/677,747.
Amendment under 37 CFR §1.116 filed Sep. 1, 2006 in response to Official Action of Jun. 30, 2006 in U.S. Appl. No. 10/677,747.
Official Action of Dec. 22, 2006 in U.S. Appl. No. 10/677,747 (with attachments).
Amendment under 37 CFR §1.116 filed Feb. 6, 2007 in response to Official Action of Dec. 22, 2006 in U.S. Appl. No. 10/677,747.
Official Action of Jul. 5, 2007 in U.S. Appl. No. 10/677,747 (with attachments).
Amendment filed Oct. 4, 2007 in response to Official Action of Jul. 5, 2007 in U.S. Appl. No. 10/677,747.
Official Action of May 28, 2008 in U.S. Appl. No. 10/677,747.
Challa, R., et al.; “Cyclodextrins in Drug Delivery: An Updated Review”;AAPS PharmSciTech 2005; Oct. 14, 2005; pp. E329-E357; 6 (2) Article 43; Department of Pharmaceutics, Faculty of Pharmacy, Hamdard University, New Delhi, India.
Lofisson, T., et al.; “Cyclodextrins in Drug Delivery”;Expert Opinion Drug Delivery; 2005; pp. 335-351; 2 (2); Ashley Publications; University of Iceland, Faculty of Pharmacy, Hagi, Hofivallagata, Iceland.
Japan Pharmaceutical Excipients Council edit, Pharmaceutical Excipients Directory, section “propylene glycol,” 1994, pp. 114.
Ansley, David M. et al., “High dose propofol enhances red cell antioxidant capacity during CPB in humans,”Can J Anaesth1999, 46:7(641-648).
Cheng, Ya-Jung et al., “Small-Dose Propofol Sedation Attenuates the Formation of Reactive Oxigen Species in Tourniquet-Induced Ischemia-Reperfusion Injury Under Spinal Anesthesia,”Anesth Analg 2002, 94:6(1617-1620).
Daskalopoulos, Rina et al., “Accumulation of Intracellular Ascorbate From Dehydroascorbic Acid by Astrocytes Is Decreased After Oxidative Stress and Restored by Propofol,”GLIA 2002,39:124(124-132). .
De La Cruz, J.P. et al., “Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes,”Br J Pharmacol 1999, 128:7(1538-1544).
De Riu, P. L. et al., “Disposition of propofol between red blood cells, plasma, brain and cerebrospinal fluid in rabbits,”Eur J Anaesthesiol 2000, 17:1(18-22).
Ergün, Rüchan et al., “Neuroprotective effects of propofol following global cerebral ischemia in rats,”Neurosurg Rev 2002,25:1-2(95-98).
Lin, C. -R. et al., “Effect of thiopental, propofol, and etomidate on vincristine toxicity in PC12 cells,”Cell Biol Toxicol 2002, 18:1(63-70).
Murphy, P. G. et al., “Effect of propofol and thiopentone on free radical mediated oxidative stress of the erythrocyte,”Br J Anaesth 1996, 76:4(536-543).
Runzer, Tim D. et al., “Tissue Antioxidant Capacity During Anesthesia: Propofol Enhances In Vivo Red Cell and Tissue Antioxidant Capacity in a Rat Model,”Anesth Analg 2002, 94:1(89-93).
Wilson, John X. et al., “Free Radicals, Antioxidants, and Neurologic Injury: Possible Relationship to Cerebral Protection by Anesthetics,”J Neurosurg Anesthesia 2002, 14:1(66-79).
F.F. Busta et al., Chemical Food Preservatives, Antimicrobial Preservatives and Protectants, Chapter 35, pp. 656-694 , Seymour Block, Ed:1983 (3rd edition).
P. Bulet et al., Antimicrobial Peptides in Insects; Structure and Function, Developmental and Comparative Immunology, 23 (1999) 329-3
Almarsson Orn
Chen Hongming
Zhang Zhong
Gembeh Shirley V
Hayes Robert C
RatnerPrestia
Transform Pharmaceuticals Inc.
LandOfFree
Aqueous 2,6-diisopropylphenol pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aqueous 2,6-diisopropylphenol pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aqueous 2,6-diisopropylphenol pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2655229